FI110061B - Förfarande för framställning av ett transdermalt terapeutiskt system med en kristallisationsinhibitor - Google Patents

Förfarande för framställning av ett transdermalt terapeutiskt system med en kristallisationsinhibitor Download PDF

Info

Publication number
FI110061B
FI110061B FI942011A FI942011A FI110061B FI 110061 B FI110061 B FI 110061B FI 942011 A FI942011 A FI 942011A FI 942011 A FI942011 A FI 942011A FI 110061 B FI110061 B FI 110061B
Authority
FI
Finland
Prior art keywords
som
och
transdermal therapeutic
crystallization
therapeutic system
Prior art date
Application number
FI942011A
Other languages
English (en)
Finnish (fi)
Other versions
FI942011A0 (sv
FI942011A (sv
Inventor
Jutta Riedl
Ralph Lipp
Johannes Tack
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI942011A0 publication Critical patent/FI942011A0/sv
Publication of FI942011A publication Critical patent/FI942011A/sv
Application granted granted Critical
Publication of FI110061B publication Critical patent/FI110061B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI942011A 1991-10-31 1994-04-29 Förfarande för framställning av ett transdermalt terapeutiskt system med en kristallisationsinhibitor FI110061B (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE4136057 1991-10-31
DE4136057 1991-10-31
DE4210711A DE4210711A1 (de) 1991-10-31 1992-03-27 Transdermale therapeutische systeme mit kristallisationsinhibitoren
DE4210711 1992-03-27
PCT/EP1992/002478 WO1993008795A1 (de) 1991-10-31 1992-10-21 Transdermale therapeutische systeme mit kristallisationsinhibitoren
EP9202478 1992-10-21

Publications (3)

Publication Number Publication Date
FI942011A0 FI942011A0 (sv) 1994-04-29
FI942011A FI942011A (sv) 1994-04-29
FI110061B true FI110061B (sv) 2002-11-29

Family

ID=25908725

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942011A FI110061B (sv) 1991-10-31 1994-04-29 Förfarande för framställning av ett transdermalt terapeutiskt system med en kristallisationsinhibitor

Country Status (14)

Country Link
EP (1) EP0610357B1 (sv)
JP (1) JP3526864B2 (sv)
AT (1) ATE158181T1 (sv)
AU (2) AU2895392A (sv)
CA (1) CA2120599C (sv)
DE (2) DE4210711A1 (sv)
DK (1) DK0610357T3 (sv)
ES (1) ES2106888T3 (sv)
FI (1) FI110061B (sv)
GR (1) GR3025237T3 (sv)
HU (1) HU227531B1 (sv)
NO (1) NO307644B1 (sv)
PT (1) PT101019B (sv)
WO (1) WO1993008795A1 (sv)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JPH08512054A (ja) * 1993-06-25 1996-12-17 アルザ・コーポレーション 経皮系におけるポリ−ｎ−ビニルアミドの含有
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Preparations given through the skin of unstable anti-acid drugs
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
DE19500662C2 (de) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster und seine Verwendung
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
CA2222133C (en) † 1995-06-07 2002-12-24 Cygnus, Inc. Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
DE19649535C2 (de) * 1996-11-29 2000-02-10 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines pflasterförmigen therapeutischen Systems
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
DE19829713C1 (de) * 1998-07-03 2000-01-05 Lohmann Therapie Syst Lts Therapeutisches System mit Zusatz von Perglanzpigmenten
DE19834006A1 (de) * 1998-07-29 2000-02-24 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen
DE19843027A1 (de) * 1998-09-19 2000-03-23 Labtec Gmbh Neohesperidin DC als Kristallisationsinhibitor
DE10012908B4 (de) * 2000-03-16 2005-03-17 Lts Lohmann Therapie-Systeme Ag Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
NZ530227A (en) * 2001-06-18 2006-09-29 Noven Pharma Enhanced drug delivery in transdermal systems
JP5619337B2 (ja) 2003-10-10 2014-11-05 フェリング ビー．ブイ． 皮膚残渣を最小限に抑えるための経皮的医薬製剤
EP1857103B1 (en) 2005-02-28 2018-10-24 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
EP2258355B1 (en) 2008-02-27 2020-01-22 Hisamitsu Pharmaceutical Co., Inc. Patch
EP2255802B1 (en) 2008-02-27 2018-01-17 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product
EP2258396B1 (en) 2008-03-03 2017-09-06 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
JP5766475B2 (ja) * 2010-03-30 2015-08-19 日東電工株式会社 貼付製剤およびその製造方法
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
US9980920B2 (en) 2013-09-11 2018-05-29 Medrx Co., Ltd. Base composition for tape agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512358D0 (en) * 1985-05-16 1985-06-19 Euro Celtique Sa Transdermal delivery system
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
WO1991005529A1 (en) * 1989-10-13 1991-05-02 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
JPH07116032B2 (ja) * 1990-04-06 1995-12-13 積水化学工業株式会社 ニトログリセリン貼付剤

Also Published As

Publication number Publication date
FI942011A0 (sv) 1994-04-29
DE4210711A1 (de) 1993-05-06
DK0610357T3 (da) 1998-05-11
AU712692B2 (en) 1999-11-11
PT101019B (pt) 1999-10-29
ATE158181T1 (de) 1997-10-15
HU227531B1 (en) 2011-07-28
HUT72964A (en) 1996-06-28
NO941593L (no) 1994-04-29
NO307644B1 (no) 2000-05-08
JPH07506083A (ja) 1995-07-06
CA2120599C (en) 2003-04-15
HU9401257D0 (en) 1994-08-29
ES2106888T3 (es) 1997-11-16
AU1652997A (en) 1997-05-29
EP0610357B1 (de) 1997-09-17
CA2120599A1 (en) 1993-05-13
DE59208918D1 (de) 1997-10-23
WO1993008795A1 (de) 1993-05-13
FI942011A (sv) 1994-04-29
EP0610357A1 (de) 1994-08-17
PT101019A (pt) 1994-02-28
JP3526864B2 (ja) 2004-05-17
GR3025237T3 (en) 1998-02-27
NO941593D0 (sv) 1994-04-29
AU2895392A (en) 1993-06-07

Similar Documents

Publication Publication Date Title
FI110061B (sv) Förfarande för framställning av ett transdermalt terapeutiskt system med en kristallisationsinhibitor
US5676968A (en) Transdermal therapeutic systems with crystallization inhibitors
US6153216A (en) Transdermal estradiol/progestogen agent patch and its production
US5904931A (en) Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide
TW537899B (en) Composition for the transdermal administration of steroid drugs
HU217215B (hu) Eljárás transzdermális gyógyászati rendszerek előállítására
US20060088580A1 (en) Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion
CA2049288A1 (en) Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
JPH10510823A (ja) 多数の活性成分を同時に放出するための経皮システム
JP2002508778A (ja) 性ステロイドホルモンの適用のための経皮治療系
SK280493B6 (sk) Samolepiaca náplasť na transdermálnu aplikáciu sys
US6013276A (en) Transdermal matrix system
NZ533159A (en) Transdermal therapeutic systems containing steroid hormones and propylene glycol monocaprylate
JP2002521427A (ja) ホルモンの経皮投与用エストラジオール含有パッチ
JPS63255217A (ja) 活性成分を経皮投与するための粘着性マトリックスおよびその製造方法
AU2011298892B2 (en) Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
PL162410B1 (pl) Sposób wytwarzania poprzezskórnego ukladu terapeutycznegoNumer zgloszenia, z którego nastapilo wydzielenie:282033 PL
AU2015203180B2 (en) Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
JP2003534271A (ja) 活性物質の結晶化が減少された性質を有する経皮治療システム
MXPA00000079A (en) Transdermal therapeutic system (tts) for administering sexual steroid hormones
MXPA00000065A (en) Therapeutical system for transdermal delivery of levonorgestrel
TW201311452A (zh) 具抑制結晶保護膜（離型襯墊）之經皮治療系統

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: BAYER INTELLECTUAL PROPERTY GMBH

MA Patent expired